LOXL2 and nonpapillary renal cell carcinoma: Mechanistically, LOX and LOXL2 promote collagen stiffness increment, integrin α5β1 stabilization, and fiber formation while suppressing the protease and proteasome system in ccRCC (Hase et al., 2014).